**Core Concept**
Alkylating agents are a class of chemotherapeutic drugs that work by adding an alkyl group to the DNA of cancer cells, thereby interfering with their replication and inducing cell death. They are commonly used in the treatment of various types of cancer.

**Why the Correct Answer is Right**
5-Fluorouracil (5-FU) is an antimetabolite, not an alkylating agent. It works by inhibiting thymidylate synthase, which is involved in DNA synthesis, thereby preventing cancer cells from replicating. Unlike alkylating agents, 5-FU does not directly damage DNA by adding an alkyl group. Instead, it disrupts the normal metabolic pathways of cancer cells, ultimately leading to their death.

**Why Each Wrong Option is Incorrect**
**Option B:** Melphalan is indeed an alkylating agent, used in the treatment of multiple myeloma and ovarian cancer. It works by cross-linking DNA strands, thereby inhibiting cancer cell replication.

**Option C:** Cyclophosphamide is also an alkylating agent, commonly used in the treatment of various types of cancer, including leukemia, lymphoma, and breast cancer. It works by adding an alkyl group to DNA, which leads to DNA damage and cell death.

**Option D:** Chlorambucil is another alkylating agent, used in the treatment of chronic lymphocytic leukemia and other types of cancer. It works by adding an alkyl group to DNA, which leads to DNA damage and cell death.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that alkylating agents can cause bone marrow suppression, leading to a decrease in the production of blood cells. This can result in anemia, infection, and bleeding, making it crucial to monitor patients closely for these side effects.

**✓ Correct Answer:** A. 5-FU